Guidelines for radioiodine therapy of differentiated thyroid cancer
about
Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid CancerThyroid computed tomography imaging: pictorial review of variable pathologies.Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide TherapyManagement Guidelines for Children with Thyroid Nodules and Differentiated Thyroid CancerImaging of thyroid carcinoma with CT and MRI: approaches to common scenariosGerman Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerImproved detection of lung or bone metastases with an I-131 whole body scan on the 7th day after high-dose I-131 therapy in patients with thyroid cancerAssociation between Volumetric Analysis of Lung Metastases on F-18-fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computed Tomography and Short-term Progression after I-131 Therapy for Differentiated Thyroid Carcinoma.Differentiated Thyroid Cancer-Treatment: State of the Art.The pros and cons of routine central compartment neck dissection for clinically nodal negative (cN0) papillary thyroid cancerAn overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications.Update on thyroid cancer treatment.Is the image quality of I-124-PET impaired by an automatic correction of prompt gammas?Heath-related quality of life in thyroid cancer patients following radioiodine ablation.Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.Recombinant TSH stimulated remnant ablation therapy in thyroid cancer: the success rate depends on the definition of ablation success--an observational study.Cancer stratification by molecular imaging.Changes in the pulmonary function test after radioactive iodine treatment in patients with pulmonary metastases of differentiated thyroid cancer.Diagnosis and treatment of patients with thyroid cancer.Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake.Use of radioactive iodine for thyroid cancer.Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging.The Evaluation of Microcarcinoma in Differentiated Thyroid Cancers According to Old and New TNM Classification.Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma.Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan and Elevated Thyroglobulin Level or Positive Anti-thyroglobulin Antibody.Association between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer.Quality of life-in patients with differentiated thyroid cancer at the general endocrinology clinics of the University Hospital of Puerto RicoEstimating (131)I biokinetics and radiation doses to the red marrow and whole body in thyroid cancer patients: probe detection versus image quantification.Targeted radionuclide therapy.Low iodine diet for preparation for radioactive iodine therapy in differentiated thyroid carcinoma in KoreaSingle photon emission computed tomography imaging for temporal dynamics of thyroidal and salivary radionuclide accumulation in 17-allyamino-17-demothoxygeldanamycin-treated thyroid cancer mouse model.Urinary iodine: comparison of a simple method for its determination in microplates with measurement by inductively-coupled plasma mass spectrometry.Pediatric papillary thyroid cancer: current management challengesPreparation for radioactive iodine therapy is not a risk factor for the development of hyponatremia in thyroid cancer patients.Lung uptake on I-131 therapy and short-term outcome in patients with lung metastasis from differentiated thyroid cancer.Radioiodine for remnant ablation and therapy of metastatic disease.The role of nuclear medicine in differentiated thyroid cancer.Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma.Predicting tumour response.
P2860
Q26744936-ED9AD01A-59EA-4CF2-8CB5-0E20717B8B72Q26748491-669086B2-21DE-473A-8EC7-87D8A719767FQ26768478-96C3AEF8-710E-4D8D-8B80-8E468A2AD5D7Q26829349-CD50B2E1-0491-457B-9F71-E0ED0B833600Q26995608-471B6033-EBDA-4B09-BED9-1E0ED33BFBE6Q30317867-0B79D2EC-05A5-47D0-A63C-4661DA2417C6Q30367068-2AB56D53-431A-4D89-B6D4-CA304E3C0815Q33704024-5DEBCF62-E893-4304-A90E-D069BF17FDEEQ33827725-5A0D561A-F316-4051-9A29-90FB97EE2957Q33839037-C57133D4-D2FC-457F-9F4D-A94B2EBA236FQ33973101-F6ACAC70-11BA-4430-9307-31DD5CFD55FCQ34093032-A0200EFC-4656-4412-B1E6-96A429BD3257Q34310219-ED5F32AB-5F05-4533-A106-ABEAD74676BBQ34981083-D5BB271B-808A-441D-82E3-8D478128457FQ35047576-0D160791-12F5-4292-B2E4-4EA3F7E40220Q35163702-1353443F-AC12-4DEC-A221-9921E3C01D58Q35201397-86F60F2B-8887-4538-B503-15B7EC3768BAQ35380664-F4F2C689-0FBA-4407-9CD3-427BA0EB24B0Q35553559-4F76091D-FD26-44CC-9272-D55D6A698495Q35555583-93F06D39-A485-4DDB-9AC0-91F2595958C3Q35850033-1166E9C8-53F3-4918-910A-F079B3322D65Q35961413-01C0F500-B45C-44A9-A97B-531285A9DCDBQ35984456-E16B7EBD-09AB-4A47-BB8F-B20B36A472D3Q36664600-48410329-4D7F-4CC5-A7A5-9B3FF78E3E2CQ36710074-90B8B832-D5D0-4192-9B05-DEC10EB53A2DQ36910265-4F655616-BD13-4662-A666-5DF3EC756190Q36910859-C3542F14-222D-48E7-8D6E-8F46CE86705AQ37031648-8B144C2F-0D66-44EC-973E-C9459D1BB7D7Q37079244-18F1C3C9-2507-4F66-AA8B-B99DED1B4B25Q37148148-37C994DA-22F0-437B-86AA-1A930279898EQ37264466-417B5545-7D48-4648-AAF0-FF3B8A6862B6Q37518427-46F0CAAB-5152-4114-9EC5-89B0D24560EDQ37550208-00E885C6-0ED8-4212-BF44-0616D3C09EECQ37551856-A86E6D2E-50A0-4D88-9177-F4014D27B881Q37626655-3DC58B19-0412-42D5-A4D3-ADD5E1E90C6CQ37677047-34F107ED-08A7-4597-AF9E-7034A0C9EEF6Q37913996-BCA4E0D8-14CE-419C-BB39-8F988F63A13AQ38027799-2C88BF21-28A6-4206-BED9-0D24727E5A9EQ38055493-D7FE2B0A-F6D1-4198-B625-2CB580EF810BQ38141699-03719CD8-C22E-4F86-BF82-18CBBCACD7B2
P2860
Guidelines for radioiodine therapy of differentiated thyroid cancer
description
im Oktober 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 October 2008
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2008
@uk
name
Guidelines for radioiodine therapy of differentiated thyroid cancer
@en
Guidelines for radioiodine therapy of differentiated thyroid cancer
@nl
type
label
Guidelines for radioiodine therapy of differentiated thyroid cancer
@en
Guidelines for radioiodine therapy of differentiated thyroid cancer
@nl
prefLabel
Guidelines for radioiodine therapy of differentiated thyroid cancer
@en
Guidelines for radioiodine therapy of differentiated thyroid cancer
@nl
P2093
P1476
Guidelines for radioiodine therapy of differentiated thyroid cancer
@en
P2093
E Bombardieri
European Association of Nuclear Medicine (EANM)
J Tennvall
M Dietlein
S E Clarke
P2888
P304
P356
10.1007/S00259-008-0883-1
P577
2008-10-01T00:00:00Z